PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 158 filers reported holding PDL BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $110,000 | +66.7% | 37,863 | +63.9% | 0.01% | +266.7% |
| Q4 2018 | $66,000 | -40.0% | 23,100 | -34.4% | 0.00% | -40.0% |
| Q2 2016 | $110,000 | -67.6% | 35,200 | -65.6% | 0.01% | -68.8% |
| Q1 2016 | $340,000 | +119.4% | 102,200 | +132.3% | 0.02% | +77.8% |
| Q4 2015 | $155,000 | +112.3% | 44,000 | +323.1% | 0.01% | +28.6% |
| Q1 2015 | $73,000 | -37.6% | 10,400 | -14.0% | 0.01% | -66.7% |
| Q2 2014 | $117,000 | +36.0% | 12,100 | +8.0% | 0.02% | +40.0% |
| Q2 2013 | $86,000 | – | 11,200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HAYS ADVISORY LLC | 1,037,600 | $6,672,000 | 0.97% |
| Global X Management CO LLC | 2,435,411 | $15,660,000 | 0.86% |
| Advisors Asset Management, Inc. | 5,373,113 | $34,549,000 | 0.47% |
| Gotham Asset Management, LLC | 7,233,838 | $46,514,000 | 0.39% |
| TFS CAPITAL LLC | 582,438 | $3,745,000 | 0.37% |
| LOMBARDIA CAPITAL PARTNERS LLC | 1,637,611 | $10,530,000 | 0.36% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 95,122 | $611,634,000 | 0.33% |
| FIRST TRUST ADVISORS LP | 17,536,793 | $112,762,000 | 0.29% |
| Arrow Investment Advisors, LLC | 214,595 | $1,380,000 | 0.28% |
| GSA CAPITAL PARTNERS LLP | 954,853 | $6,140,000 | 0.24% |